Current issues in nuclear cardiology

British Journal of Radiology

Volumn 81, Issue 964, 2008, Pages 270-274

  Tonge, C M ^a   Fernandez, R C ^b   Harbinson, M T ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ACETIC ACID C 11; AMMONIA N 13; CADMIUM; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; STRONTIUM 82; TETROFOSMIN TC 99M; TRASTUZUMAB; WATER O 15; ZINC; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TRACER;

ANGIOCARDIOGRAPHY; BREAST CANCER; CLINICAL RESEARCH; DOSIMETRY; ECHOCARDIOGRAPHY; GAMMA RADIATION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HUMAN; IMAGE QUALITY; NOTE; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CARDIOLOGY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HEART MUSCLE ISCHEMIA; INSTRUMENTATION; JAPAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OBESITY; OCCUPATIONAL EXPOSURE; SCINTISCANNING; UNITED KINGDOM; UNITED STATES;

CARDIOLOGY; CORONARY ANGIOGRAPHY; GREAT BRITAIN; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; NEUROTRANSMITTER AGENTS; NUCLEAR MEDICINE; OBESITY; OCCUPATIONAL EXPOSURE; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOACTIVE TRACERS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 42449118091     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/59260451     Document Type: Note

References (18)

1. National Institute for Health and Clinical Excellence. Trastuzumab for the adjuvant treatment of early-stage HER2-positive breast cancer. NICE Technology appraisal guidance; 2006: 107.
2. National Institute for Health and Clinical Excellence. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. NICE Technology appraisal guidance; 2003: 73.
3. Mehrige ME, Breen WJ, Shelton V, Houston T, D'Arcy BJ, Perna AF. Impact of myocardial perfusion imaging with PET and Rb-82 on downstream invasive procedure utilisation, costs and outcomes in coronary disease management. J Nucl Med 2007;48:1069-76.
4. Wu Y, Tadamura E, Yamamura M, Kanao S, Marui A, Tanabara K, et al. Comparison of contrast enhanced MRI with F-18 FDG PET/T1-201 SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularisation in chronic ischaemic heart disease. J Nucl Med 2007;48:1096-1103.
5. Santana CA, Folks RD, Garcia EV, Verdes L, Sanyal R, Hainer J, et al. Quantitative Rb-82 PET/CT: development and validation of a myocardial perfusion database. J Nucl Med 2007;48:1122-8.
6. Steed J, Brunken R. What are the benefits of Rb-82? Why do physicians order myocardial PET scans when the patient has had a myocardial SPECT scan? J Nucl Med 2007;48:445P.
7. Zhou R, Acton P D, Ferrari VA. Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 2006;48:2094-106.
8. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981;22:129-32.
9. Schleipman AR, Castronovo FP, Di Carli MF, Dorbala S. Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging. Journal of Nuclear Cardiology 2006;13:378-84.
10. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJS, Cleland JGF, et al. CHRISTMAS Study Steering Committee and Investigators. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? European Heart Journal 2000;21:1387-96.
11. Skrypniuk JV, Bailey D, Cosgriff PS, Fleming JS, Houston AS, Jarritt PH, et al. UK audit of left ventricular ejection fraction estimation from equilibrium ECG gated blood pool images. Nuclear Medicine Communications 2005;26:205-15.
12. Sugeng L, Weinert L, Lang RM. Left ventricular assessment using three dimensional echocardiography. Heart 2003;89:iii29-36.
13. Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation 2006;114:654-61.
14. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr. Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21.
15. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.
16. Giang T, Nanz D, Coulden R, Friedrich M, Graves M, Al-Saadi N, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004;25:1657-65.
17. Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006;47:1427-32.
18. Kelion AD, Anagnostopoulos C, Harbinson M, Underwood SR, Metcalfe M. Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000. Heart 2005;91:iv2-5.